Anzeige
Mehr »
Login
Freitag, 08.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YJFZ | ISIN: US5368041076 | Ticker-Symbol: L4T
Berlin
15.09.23
16:59 Uhr
0,090 Euro
0,000
0,00 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
LITHIUM CORPORATION Chart 1 Jahr
5-Tage-Chart
LITHIUM CORPORATION 5-Tage-Chart
ACCESSWIRE
541 Leser
Artikel bewerten:
(2)

Lithium Corporation Appoints New Exploration Manager

ELKO, NV / ACCESSWIRE / February 29, 2024 / Lithium Corporation (OTCQB:LTUM) ("LTUM" or "the Company"), a North American exploration mining company focused on energy metals for the growing energy storage sector and high-tech industries, is pleased to advise investors the Company recently expanded its internal geological expertise and knowledge with the engagement of Ken Tullar, CPG, in the role of Exploration Manager, Lithium Corporation.

Mr. Tullar brings more than 35 years of professional mineral exploration & development experience in western North America, from Alaska to Mexico, with an emphasis on Nevada. His extensive background in geology, structure, geochemistry, hydrochemistry and geophysics, and specific knowledge of the Great Basin, makes him a valued asset as Lithium Corp. charts a path to expanding and developing its portfolio of lithium and other energy metals prospects. Tom Lewis, President & CEO, Lithium Corp. commented, "We've been talking to Ken for quite some time with respect to coming to work with Lithium Corporation and are very pleased he agreed to come over and be part of the team."

Lithium Corporation President & CEO Tom Lewis will be available to answer shareholder and investor questions and discuss the status of exploration initiatives on the Company's Nevada and British Columbia prospects at the Prospectors and Developers Association of Canada (PDAC) Annual Convention March 3 - 6, 2024 in Toronto, Canada. Please contact the Company at info@lithiumcorporation.com in advance to arrange.

Learn more about Lithium Corporation's complete portfolio of lithium, graphite, and titanium/rare earth elements prospects: https://lithiumcorporation.com/projects/

About Lithium Corporation

Lithium Corporation is a Nevada based mineral exploration company and one of a handful of Project Generators in the critical minerals space in North America. The Company's dual operational focuses cover exploration activities on several lithium prospects in Nevada, USA, as well as titanium/rare earth elements & graphite properties in British Columbia, Canada. Lithium Corp. has maintained a strategic alliance with Morella Corporation (the Company's single largest shareholder) for the past nine years and apart from the Fish Lake Valley agreement, also has a formal agreement with Morella covering earn-ins on the Company's North Big Smoky lithium-in-brine prospect in Nye County, Nevada.

Website: www.lithiumcorporation.com

Contact Info
Tom Lewis, CEO
775-410-5287
info@lithiumcorporation.com

About Morella Corporation

Morella is an exploration and resource development company focused on lithium and battery minerals. Morella is currently engaged in exploration, resource definition and development activities with projects strategically located in Tier 1 mining jurisdictions in both Australia and the United States. Morella will secure and develop lithium raw materials to support the surging demand for battery minerals, critical in enabling the global transition to green energy.

Contact Info
James Brown, Managing Director
info@morellacorp.com

Notice Regarding Forward-Looking Statements

This current report contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of minerals prices, and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Lithium Corporation (OTC-LTUM) 1031 Railroad St. Ste 102B Elko NV 89801 (775) 410-5287 www.lithiumcorporation.com

SOURCE: Lithium Corporation



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.